“…SCAs have been broadly grouped into three categories, as proposed by Harding based on cerebellar ataxia, ophthalmoplegia, and associated clinical symptoms [Harding, 1993;Duenas et al, 2006;Everett and Wood, 2004]. Autosomal dominant cerebellar ataxia (ADCA)-I, a more heterogeneous group that includes SCA1, SCA2, SCA3, SCA4, SCA8, SCA12, SCA13, SCA18-25, SCA27-29, and dentatorubral-pallidoluysian atrophy (DRPLA), presents with pyramidal features, extrapyramidal signs, and amyotrophy [Orr et al, 1993;Imbert et al, 1996;Pulst et al, 1996;Kawaguchi et al, 1994;Flanigan et al, 1996;Koob et al, 1999;Holmes et al, 1999;Waters et al, 2006;Devos et al, 2001;Verbeek et al, 2004;Knight et al, 2004;Vuillaume et al, 2002;Chung et al, 2003;Schelhaas et al, 2004;Swartz et al, 2002;Stevanin et al, 2005;Yu et al, 2005;van Swieten et al, 2003;Cagnoli et al, 2006;Koide et al, 1994]. Additionally, pigmentary retinal degeneration and seizures are observed in ADCA-II (SCA7) and ADCA-IV (SCA10 and SCA17), respectively [David et al, 1997;Matsuura et al, 2000;Nakamura et al, 2001].…”